Trial NCT05209529

View at ClinicalTrials.gov 
Org. Study IDs: EORTC-1984-BCG
Secondary IDs: 2022-003594-33

Last trial update was posted on 2024-02-23

MeSH Interventions

Durvalumab Olaparib

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

BRCA1 Mutation BRCA2 Mutation TNBC - Triple-Negative Breast Cancer

Stopping Reasons

Withdrawn interest from grant provider

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID